Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.
about
Cantharidin alters the expression of genes associated with the NKG2D-associated immune response in TSGH-8301 human bladder carcinoma cells.Defective quorum sensing of acute lymphoblastic leukemic cells: evidence of collective behavior of leukemic populations as semi-autonomous aberrant ecosystems.Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.
P2860
Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.
@ast
Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.
@en
type
label
Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.
@ast
Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.
@en
prefLabel
Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.
@ast
Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.
@en
P2093
P2860
P1476
Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.
@en
P2093
Charles Owens
Dan Theodorescu
Garrett M Dancik
Henry F Frierson
Jason E Duex
Jonathan Hensel
Michael G Edwards
P2860
P304
P356
10.1158/1541-7786.MCR-15-0130
P577
2015-06-15T00:00:00Z